Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sumber Sinergi Makmur Tbk. (IOTF) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Sumber Sinergi Makmur Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Sumber Sinergi Makmur Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Sumber Sinergi Makmur Tbk. trades at Rp72 (market cap 386.19B, 248.07M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Sumber Sinergi Makmur Tbk. is far larger — about 2.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Sumber Sinergi Makmur Tbk. is more actively traded (248.07M versus 187.4K). Which is the better fit depends on your goals.

IOTFOBAT
Market Cap
386.19B164.65B
Volume
248.07M187.4K
Lot
2.48M1.87K
Turnover
18.39B44.35M
Average Price
74.12236.67
Value
18.39B44.35M
Indicative Equilibrium Price
72242
Indicative Equilibrium Volume
35.51K500

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IOTF
View details
OBAT
View details

About Sumber Sinergi Makmur Tbk.

PT Sumber Sinergi Makmur Tbk (the Company) was established based on Deed Number 88 dated May 19, 2015 of H. Zainuddin, S.H., a notary domiciled in Jakarta. The company started its commercial activities in 2015. The controlling party of the Company and the party who is the ultimate beneficial owner of the Company is Alamsyah.

Read more on IOTF

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT